NHS National Proprietary Pharmaceuticals – Intravenous (IV) Fluids, Topical Solutions, Urological Solutions & Gelatins 1 June 2026 – CM/PHR/25/5727
Period of Framework Agreement: 1 June 2026 to 31 May 2028 with an option or option(s) to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.
CM/PHR/25/5727/01 – High Use Lines Regionally Awarded to 1 Supplier
CM/PHR/25/5727/02 – Not Regionally Awarded Lines
CM/PHR/25/5727/03 – All Lines…

You must be logged in to view the rest of this content, click here to login

Don't have an account, click to sign up for our 14-day free trial.